These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30900859)

  • 21. Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
    Chen Z; Zhu X; Geng Y; Dai J; Tang S; Adams E; Chen D; Yuan Y
    J Pharm Biomed Anal; 2022 Nov; 221():115061. PubMed ID: 36183632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impurity profile and spectrum characteristics of the isomers in cefamandole nafate using high- performance liquid chromatography/high-performance size exclusion chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Gao J; Chen H; Zhu B; Li P; Wang J; Hong L
    Rapid Commun Mass Spectrom; 2022 Dec; 36(23):e9399. PubMed ID: 36114650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Tang K; Zhu B; Zheng S; Zheng J; Hong L
    J Pharm Biomed Anal; 2021 Sep; 204():114279. PubMed ID: 34340019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS.
    Wang J; Zheng S; Xu Y; Hu H; Shen M; Tang L
    J Pharm Biomed Anal; 2018 Nov; 161():399-406. PubMed ID: 30205304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC-MS/MS, and 2DNMR.
    Baksam V; Nimmakayala S; Devineni SR; Muchumarri RMR; Shandilya S; Kumar P
    J Pharm Biomed Anal; 2021 Oct; 205():114297. PubMed ID: 34391137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS.
    Raman B; Sharma BA; Ghugare PD; Karmuse PP; Kumar A
    J Pharm Biomed Anal; 2009 Oct; 50(3):377-83. PubMed ID: 19556091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a new component and impurities in josamycin by trap-free two-dimensional liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
    Liu G; Xu Y; Sang J; Zhu B; Wang J
    Rapid Commun Mass Spectrom; 2019 Jun; 33(12):1058-1066. PubMed ID: 30907019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
    Zhou H; Tai Y; Sun C; Pan Y
    J Pharm Biomed Anal; 2005 Feb; 37(1):97-107. PubMed ID: 15664748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel two-dimensional liquid chromatography - Mass spectrometry method for direct drug impurity identification from HPLC eluent containing ion-pairing reagent in mobile phases.
    Long Z; Zhan Z; Guo Z; Li Y; Yao J; Ji F; Li C; Zheng X; Ren B; Huang T
    Anal Chim Acta; 2019 Feb; 1049():105-114. PubMed ID: 30612641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semi-preparative high-resolution recycling liquid chromatography.
    Gritti F; Basile M; Cormier S; Fogwill M; Gilar M; McDonald T; Riley F; Yan Q
    J Chromatogr A; 2018 Sep; 1566():64-78. PubMed ID: 29958681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliable screening and confirmation of 156 multi-class illegal adulterants in dietary supplements based on extracted common ion chromatograms by ultra-high-performance liquid chromatography-quadrupole/time of flight-mass spectrometry.
    Kim EH; Seo HS; Ki NY; Park NH; Lee W; Do JA; Park S; Baek SY; Moon B; Oh HB; Hong J
    J Chromatogr A; 2017 Mar; 1491():43-56. PubMed ID: 28238425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of patulin from Penicillium expansum culture: high-speed counter-current chromatography (HSCCC) versus preparative high-performance liquid chromatography (prep-HPLC).
    He J; Tsao R; Yang R; Zhou T
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2009 Jan; 26(1):101-7. PubMed ID: 19680877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and identification of a major impurity in a new bulk drug candidate by preparative LC, ESI-MS(n), LC-MS-MS, and NMR.
    Li N; Yang J; Qin F; Li F; Gong P
    J Chromatogr Sci; 2007 Jan; 45(1):45-9. PubMed ID: 17254383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in technologies for determination of illegal drugs in health food].
    Chen D; Zhang H; Feng J; Zeng D
    Se Pu; 2020 Aug; 38(8):880-890. PubMed ID: 34213179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nontargeted Screening Method for Illegal Additives Based on Ultrahigh-Performance Liquid Chromatography-High-Resolution Mass Spectrometry.
    Fu Y; Zhou Z; Kong H; Lu X; Zhao X; Chen Y; Chen J; Wu Z; Xu Z; Zhao C; Xu G
    Anal Chem; 2016 Sep; 88(17):8870-7. PubMed ID: 27480407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.